The global healthcare industry continues to witness sustained demand for antihypertensive therapies as the prevalence of hypertension, chronic kidney disease, and cardiovascular disorders rises worldwide. According to Future Market Insights (FMI), the Irbesartan Market is projected to grow from USD 72.5 million in 2026 to USD 120.4 million by 2036, registering a 5.2% CAGR during the forecast...